 |
인쇄하기
취소
|
CJ to discontinue selling Hituben
CJ Cheil Jedang will not continue to maintain its strategic alliance with Takeda Korea over Hituben, a cold remedy.
CJ and Takeda Korea agreed not to renew the contract which will expire at the end of December.
Takeda Korea plans to supply Hibuben from next April, while CJ will release a new cold drug sooner or later.
Since its establishment of Korean branch, Takeda recovered Basen (vo...
CJ and Takeda Korea agreed not to renew the contract which will expire at the end of December.
Takeda Korea plans to supply Hibuben from next April, while CJ will release a new cold drug sooner or later.
Since its establishment of Korean branch, Takeda recovered Basen (vo...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.